Anixa Biosciences (ANIX) Cash from Financing Activities (2010 - 2026)
Anixa Biosciences' Cash from Financing Activities came in at $1.94 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 0.4% from $1.93 million a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Anixa Biosciences reported Cash from Financing Activities of $4.23 million, up 107.9% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $2.28 million, down 33.2% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -24.7% (FY2020 to FY2025).
- Going back by fiscal year, Cash from Financing Activities was $3.42 million in FY2024 (+833.1%), $366,000 in FY2023 (-19.0%), $452,000 in FY2022 (-98.6%) and $31.57 million in FY2021 (+235.6%).
- The fiscal Q3 2026 figure represents the highest quarterly Cash from Financing Activities since fiscal Q1 2024.
- Year-over-year, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 17.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.94 Mn |
| Oct 31, 2025 | 350,000.00 |
| Jul 31, 2025 | 1.93 Mn |
| Apr 30, 2025 | 18,000.00 |
| Jan 31, 2025 | -17,000.00 |
| Oct 31, 2024 | 106,000.00 |
| Jul 31, 2024 | 149,000.00 |
| Apr 30, 2024 | 897,000.00 |
| Jan 31, 2024 | 2.26 Mn |
| Oct 31, 2023 | 279,000.00 |
| Jul 31, 2023 | 3,000.00 |
| Apr 30, 2023 | 81,000.00 |
| Jan 31, 2023 | 3,000.00 |
| Oct 31, 2022 | -384,000.00 |
| Jul 31, 2022 | 829,000.00 |
| Oct 31, 2021 | 144,000.00 |
| Apr 30, 2021 | 25.36 Mn |
| Jan 31, 2021 | 6.06 Mn |
| Oct 31, 2020 | 1.40 Mn |
| Jul 31, 2020 | 4.85 Mn |
API Access
Anixa Biosciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();